These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 12417659)

  • 61. Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation.
    Schindowski K; Belarbi K; Bretteville A; Ando K; Buée L
    Genes Brain Behav; 2008 Feb; 7 Suppl 1(1):92-100. PubMed ID: 18184373
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cell-mediated neuroprotection in a mouse model of human tauopathy.
    Hampton DW; Webber DJ; Bilican B; Goedert M; Spillantini MG; Chandran S
    J Neurosci; 2010 Jul; 30(30):9973-83. PubMed ID: 20668182
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Early-onset axonal pathology in a novel P301S-Tau transgenic mouse model of frontotemporal lobar degeneration.
    van Eersel J; Stevens CH; Przybyla M; Gladbach A; Stefanoska K; Chan CK; Ong WY; Hodges JR; Sutherland GT; Kril JJ; Abramowski D; Staufenbiel M; Halliday GM; Ittner LM
    Neuropathol Appl Neurobiol; 2015 Dec; 41(7):906-25. PubMed ID: 25763777
    [TBL] [Abstract][Full Text] [Related]  

  • 64. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein.
    Probst A; Götz J; Wiederhold KH; Tolnay M; Mistl C; Jaton AL; Hong M; Ishihara T; Lee VM; Trojanowski JQ; Jakes R; Crowther RA; Spillantini MG; Bürki K; Goedert M
    Acta Neuropathol; 2000 May; 99(5):469-81. PubMed ID: 10805089
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characteristics of TBS-extractable hyperphosphorylated tau species: aggregation intermediates in rTg4510 mouse brain.
    Sahara N; DeTure M; Ren Y; Ebrahim AS; Kang D; Knight J; Volbracht C; Pedersen JT; Dickson DW; Yen SH; Lewis J
    J Alzheimers Dis; 2013; 33(1):249-63. PubMed ID: 22941973
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease.
    Brion JP; Tremp G; Octave JN
    Am J Pathol; 1999 Jan; 154(1):255-70. PubMed ID: 9916940
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hippocampal neuronal subpopulations are differentially affected in double transgenic mice overexpressing frontotemporal dementia and parkinsonism linked to chromosome 17 tau and glycogen synthase kinase-3beta.
    Engel T; Goñi-Oliver P; Gomez-Ramos P; Morán MA; Lucas JJ; Avila J; Hernández F
    Neuroscience; 2008 Dec; 157(4):772-80. PubMed ID: 18951953
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impairments in impulse control in mice transgenic for the human FTDP-17 tauV337M mutation are exacerbated by age.
    Lambourne SL; Humby T; Isles AR; Emson PC; Spillantini MG; Wilkinson LS
    Hum Mol Genet; 2007 Jul; 16(14):1708-19. PubMed ID: 17517691
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A novel mutation at position +12 in the intron following exon 10 of the tau gene in familial frontotemporal dementia (FTD-Kumamoto).
    Yasuda M; Takamatsu J; D'Souza I; Crowther RA; Kawamata T; Hasegawa M; Hasegawa H; Spillantini MG; Tanimukai S; Poorkaj P; Varani L; Varani G; Iwatsubo T; Goedert M; Schellenberg DG; Tanaka C
    Ann Neurol; 2000 Apr; 47(4):422-9. PubMed ID: 10762152
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17.
    Hong M; Zhukareva V; Vogelsberg-Ragaglia V; Wszolek Z; Reed L; Miller BI; Geschwind DH; Bird TD; McKeel D; Goate A; Morris JC; Wilhelmsen KC; Schellenberg GD; Trojanowski JQ; Lee VM
    Science; 1998 Dec; 282(5395):1914-7. PubMed ID: 9836646
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A new case of frontotemporal dementia and parkinsonism resulting from an intron 10 +3-splice site mutation in the tau gene: clinical and pathological features.
    Tolnay M; Grazia Spillantini M; Rizzini C; Eccles D; Lowe J; Ellison D
    Neuropathol Appl Neurobiol; 2000 Aug; 26(4):368-78. PubMed ID: 10931371
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vivo analysis of wild-type and FTDP-17 tau transgenic mice.
    Götz J; Barmettler R; Ferrari A; Goedert M; Probst A; Nitsch RM
    Ann N Y Acad Sci; 2000; 920():126-33. PubMed ID: 11193141
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tau protein pathology in neurodegenerative diseases.
    Spillantini MG; Goedert M
    Trends Neurosci; 1998 Oct; 21(10):428-33. PubMed ID: 9786340
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tau assembly in inducible transfectants expressing wild-type or FTDP-17 tau.
    DeTure M; Ko LW; Easson C; Yen SH
    Am J Pathol; 2002 Nov; 161(5):1711-22. PubMed ID: 12414518
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cooexpression of FTDP-17 tau and GSK-3beta in transgenic mice induce tau polymerization and neurodegeneration.
    Engel T; Lucas JJ; Gómez-Ramos P; Moran MA; Avila J; Hernández F
    Neurobiol Aging; 2006 Sep; 27(9):1258-68. PubMed ID: 16054268
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tau-tubulin kinase 1 enhances prefibrillar tau aggregation and motor neuron degeneration in P301L FTDP-17 tau-mutant mice.
    Xu J; Sato S; Okuyama S; Swan RJ; Jacobsen MT; Strunk E; Ikezu T
    FASEB J; 2010 Aug; 24(8):2904-15. PubMed ID: 20354135
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene].
    Velasco A; Fraser G; Delobel P; Ghetti B; Lavenir I; Goedert M
    FEBS Lett; 2008 Mar; 582(6):901-6. PubMed ID: 18291106
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice.
    Ikeda M; Shoji M; Kawarai T; Kawarabayashi T; Matsubara E; Murakami T; Sasaki A; Tomidokoro Y; Ikarashi Y; Kuribara H; Ishiguro K; Hasegawa M; Yen SH; Chishti MA; Harigaya Y; Abe K; Okamoto K; St George-Hyslop P; Westaway D
    Am J Pathol; 2005 Feb; 166(2):521-31. PubMed ID: 15681835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.